➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Mallinckrodt
AstraZeneca
Moodys
Medtronic

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

Ergotamine tartrate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for ergotamine tartrate and what is the scope of patent protection?

Ergotamine tartrate is the generic ingredient in four branded drugs marketed by 3M, Tersera Theraps Llc, Watson Labs Inc, and Organon Usa Inc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for ergotamine tartrate. One supplier is listed for this compound.

Drug Prices for ergotamine tartrate

See drug prices for ergotamine tartrate

Pharmacology for ergotamine tartrate

US Patents and Regulatory Information for ergotamine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera Theraps Llc ERGOMAR ergotamine tartrate TABLET;SUBLINGUAL 087693-001 Feb 24, 1983 RX No Yes   Start Trial   Start Trial   Start Trial
Organon Usa Inc WIGRETTES ergotamine tartrate TABLET;SUBLINGUAL 086750-001 Jul 29, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
3m MEDIHALER ERGOTAMINE ergotamine tartrate AEROSOL, METERED;INHALATION 012102-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Baxter
Boehringer Ingelheim
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.